Buscar
Psyence Biomedical Ltd
PBMWWAñadir a la lista de seguimiento
0.029USD
+0.003+16.19%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
0.00Cap. mercado
--P/E TTM
Más Datos de Psyence Biomedical Ltd Compañía
Psyence Biomedical Ltd is a Canada-based company, which develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The Company has partnered with iNGENu Pty Ltd (iNGENu) to conduct the Company’s clinical trial in palliative care. iNGENu is an Australia-based, globally focused contract research organization (CRO) with experience working in the psychedelic pharmaceutical drug development and clinical research industry. Its Phase IIb clinical trial, using PEX010, a 25mg naturally derived psilocybin drug candidate product in-licensed by the Company, in the palliative care setting.
Información de Psyence Biomedical Ltd
Símbolo de cotizaciónPBMWW
Nombre de la empresaPsyence Biomedical Ltd
Fecha de salida a bolsaDec 10, 2021
Director ejecutivoDr. Neil Maresky
Número de empleados- -
Tipo de seguridadCompany Warrant
Fin del año fiscal- -
Dirección121 Richmond Street West Penthouse
CiudadTORONTO
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísCanada
Código postalM5H 2K1
Teléfono17744604171
Sitio Web
Símbolo de cotizaciónPBMWW
Fecha de salida a bolsaDec 10, 2021
Director ejecutivoDr. Neil Maresky
Ejecutivos de Psyence Biomedical Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Jody Aufrichtig
Dr. Jody Aufrichtig
Chairman of the Board, Strategic Business Development Officer
Chairman of the Board, Strategic Business Development Officer
--
--
Dr. Neil Maresky
Dr. Neil Maresky
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Warwick Corden-Lloyd
Mr. Warwick Corden-Lloyd
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Marc Balkin
Mr. Marc Balkin
Independent Director
Independent Director
--
--
Mr. Christopher (Chris) Bull
Mr. Christopher (Chris) Bull
Independent Director
Independent Director
--
--
Dr. Seth Feuerstein
Dr. Seth Feuerstein
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Jody Aufrichtig
Dr. Jody Aufrichtig
Chairman of the Board, Strategic Business Development Officer
Chairman of the Board, Strategic Business Development Officer
--
--
Dr. Neil Maresky
Dr. Neil Maresky
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Warwick Corden-Lloyd
Mr. Warwick Corden-Lloyd
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Marc Balkin
Mr. Marc Balkin
Independent Director
Independent Director
--
--
Mr. Christopher (Chris) Bull
Mr. Christopher (Chris) Bull
Independent Director
Independent Director
--
--
Dr. Seth Feuerstein
Dr. Seth Feuerstein
Independent Director
Independent Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Psyence Biomedical Ltd?
Los cinco principales accionistas de Psyence Biomedical Ltd son: Dr. Jody Aufrichtig